In recent years, continuous flow synthesis has emerged as an enabling technology.^\[[@cit0001]\]^ At its core, pumps drive fluids through reactor coils where solutions can be heated above their atmospheric boiling points,^\[[@cit0002]\]^ rapidly cooled,^\[[@cit0002],\ [@cit0003]\]^ and effectively irradiated.^\[[@cit0004]\]^ Additionally, hazardous reactions can be safely processed on scale by ensuring only small quantities of hazardous material exist at any given time.^\[[@cit0001],\ [@cit0005]\]^ With these benefits in mind, our laboratory is interested in improving the synthesis of active pharmaceutical ingredients (APIs),^\[[@cit0006]\]^ commodity chemicals^\[[@cit0006],\ [@cit0007]\]^ and new materials^\[[@cit0008]\]^ through the use of continuous flow technology.

A large fraction of agrochemicals and pharmaceuticals contain highly substituted pyrazole cores with CF~2~H or CF~3~ moieties at the 3-position ([Fig. 1](#f0001){ref-type="fig"}). To create a rapid and divergent synthesis of these molecules, we envisaged the use of an assembly line synthesis.^\[[@cit0009]\]^ In an assembly line process, organic scaffolds are passed through sequential reactor modules to accrue molecular complexity. In our system, a common pyrazole core would first be synthesized, and then modified through a series of subsequent, downstream, modules to generate agrochemicals and pharmaceuticals. Choosing the order, and type, of modules would govern the substitution pattern and complexity of the final product. Herein, a multi-step continuous flow synthesis of fluorinated pyrazole cores, and their subsequent modification with additional modules is described.

![**Pharmaceuticals and agrochemicals containing common 3-fluoromethyl pyrazole cores. Colours indicate structural similarities**.](ange-2017-201704529-g001){#f0001}

The \[3+2\] cycloaddition of diazomethane with acetylene yielding pyrazole was first reported in 1898.^\[[@cit0010]\]^ More recently, 2,2-difluoromethyl diazomethane and 2,2,2-trifluoromethyl diazomethane (**1** and **2**, [Fig. 2](#f0002){ref-type="fig"}) have become common synthons in organic synthesis.^\[[@cit0011]\]^ Highly substituted pyrazoles and pyrazolines can be obtained in a single step through a reaction of **1** and **2** with alkynes and alkenes.^\[[@cit0011],\ [@cit0012]\]^ In this respect, the use of **1** and **2** would provide a cost effective approach to the construction of common pyrazole cores. However, several advancements were required to realize this goal.

![**Module 1 and 2 for the synthesis of highly substituted pyrazole and pyrazoline cores.** Unless otherwise indicated, the system used the following three solutions: a solution of CF~2~RCH2NH~2~ (2.0 equiv) and AcOH (0.4 equiv) dissolved in DCM, a second solution of ^t^BuONO (2.4 equiv) in DCM, and a third solution of the alkyne or alkene (0.79 M, 1.0 equiv) in DCM. *\[a\]* CF~3~CH~2~NH~2~ (4.0 equiv), ^t^BuONO (4.0 equiv), ACOH (0.15 equiv) and alkyne (0.79 M, 1.0 equiv). *\[b\]* CF2HCH2NH2 (0.5 equiv), tBuONO (0.8 equiv), AcOH (0.1 equiv) and alkyne (0. 79 M, 1.0 equiv). *\[c\]* CF~3~CH~2~NH~2~ (2.38 M, 4.0 equiv) and ^t^BuONO (2.86 M, 4.8 equiv) and ACOH (0.48 M, 0.8 equiv) and the alkyne (0.60 M, 1.0 equiv) with a 28 min residence time in module 2 at 132 °C with a back pressure of 325 psi. *\[d\]*. CF~2~RCH2NH~2~ (2.0 equiv), ^t^BuONO (2.0 equiv), AcOH (0.4 equiv) and alkyne (0.79 M, 1.0 equiv). *\[e\]* CF~2~RCH2NH~2~ (2.0 equiv), tBuONO (4.0 equiv), AcOH (0.5 equiv) and alkyne (0.79 M, 1.0 equiv). *\[f\]* Relative stereochemistry. The number indicated in the parentheses under compounds **25**-**33** indicates product selectivity for pyrazoline *vs* n-nitroso pyrazoline respectively. For additional details on the reactor set-up see the supporting information.](ange-2017-201704529-g002){#f0002}

Generally, \[3+2\] cycloadditions between alkynes and **1** require several hours to days,^\[[@cit0011],\ [@cit0013]\]^ while the use of **2** requires several hours and super stoichiometric amounts of Ag~2~O and NaOAc.^\[[@cit0012]\]^ Interestingly, **1** and **2** have been synthesized in continuous flow before,^\[[@cit0013]-[@cit0014]\]^ however, in the case of **1**, all reactants were placed into a syringe prior to entering the continuous flow system, posing a safety concern as the diazoalkane can be formed in the syringe.^\[[@cit0013]\]^ Furthermore, although **1** was generated in continuous flow, the \[3+2\] cycloaddition was performed at room temperature in a round bottom flask. Our control reactions indicated that generating **1** in continuous flow is inconsequential if the \[3+2\] cycloaddition is performed at room temperature (Supplementary Information). To enable the safe and beneficial use of **1** and **2** in our continuous flow system, the reactive components must be separated prior to entry, the \[3+2\] cycloaddition should be rapid for immediate diazoalkane consumption (removing a safety concern), and if possible, transformations should be catalyst free.

Our investigation began by optimizing the formation of **1** in the first module, and its subsequent consumption in a telescoped \[3+2\] cycloaddition with ethyl propiolate in the second module ([Fig. 2](#f0002){ref-type="fig"}). To our surprise, the formation of **1** required only five min at 60 °C, and the telescoped \[3+2\] cycloaddition only 10 min at 90 °C to give **3** in an excellent 92% yield (Table S1). The ability to synthesize **1** in the first module, and feed it into the second enhances reaction efficiency; passing all reagents through a single reactor coil yielded only 57%. The lower yield observed is due to less diazoalkane formation at elevated temperatures, further highlighting the benefit of reaction isolation during multi-step reactions.

The optimized system was then used to generate **2** for subsequent cycloaddition with ethyl propiolate to afford **4** in 99% yield, demonstrating this reactor set up can generate high yields of 3-trifluoromethyl pyrazoles.

With optimized conditions in hand, a range of alkynes were reacted with both **1** and **2** to yield **5-17** in moderate to excellent yields (48-99%). Importantly, the system accommodated sterically demanding alkynes **7-9** and **14-18**, and larger fluoroamines to generate **18**. As **3-6** house an ester moiety at the 5-position, it would be possible to access DPC-602 and AS-136A ([Fig. 1](#f0001){ref-type="fig"}). Other targets, however, required a synthetic handle at the 4-position. Conceivably, additional modification to **3-6** would achieve this, but forcing the electronically disfavored isomer with a malleable functional group at the 4-position would be more efficient.

Using TMS-protected alkynes drives formation of the electronically disfavored isomers **14-17** due to steric interactions between the TMS and CF~2~R (R=F or H) moieties.^\[[@cit0011],\ [@cit0015]\]^ Prior to this work, three days reactivity and five equivalents of **1** yielded **14** in only 41%.^\[[@cit0011]\]^ Here, reducing the concentration of AcOH to 15% to avoid TMS deprotection before cycloaddition while increasing both the concentration of difluoroethylamine and ^t^BuONO yielded **14-17** in good yield (59-72%) for a *15 min* residence time. Controlling the regiochemical outcome of the \[3+2\] cycloaddition generates the pyrazole core for Bixafen, Fluxapyroxad, Sedaxane and Isopyrazam ([Fig. 1](#f0001){ref-type="fig"}). Importantly, novel pyrazoles **16** and **17** have the correct oxidation state for directly achieving the target compounds.

Next, cycloaddition of **2** with terminal aryl alkynes was explored. Previous reports require stoichiometric Ag~2~O and NaOAc for 5 h, or two weeks in a sealed tube devoid of light.^\[[@cit0016]\]^ Attempting a catalyst free transformation in our continuous flow setup initially yielded no product. However, increasing the temperature and residence time (28 min) of module 2 yielded **19-24** as single regioisomers in good to excellent yields (53-93%). This continuous flow approach has several important advancements. First, requirements for super stoichiometric Ag~2~O and NaOAc have been removed. Second, the reaction time has been reduced to \~30 min. Third, the transformation is now scalable, and finally, **19** was obtained in improved yields.

This high temperature transformation again draws on a benefit of continuous flow synthesis. Operating a back pressure of 325 psi allows DCM (bp 40 °C) and 2 (bp \~13 °C)^\[[@cit0011]\]^ to be super heated without vaporization; such conditions are not amenable to round bottom flasks. Furthermore, heating diazoalkanes at high temperatures in a round bottom flask would be highly dangerous. Interestingly, the use of **1** under these conditions yielded \<30% of the desired difluoro analogue. The higher temperatures required for a catalyst free approach most likely degrades **1** as gas evolution in the reactor was observed. The use of **2** under these conditions opens up the possibility for synthesizing Celecoxib, Mavacoxib, SC-560 and the human lung cancer suppression candidate ([Fig. 1](#f0001){ref-type="fig"}) in a rapid, catalyst free, and scalable environment.

Alkenes were also explored for the synthesis of pyrazolines. From a versatility and cost standpoint, alkenes typically have greater commercial availability, and are often more affordable. Furthermore, oxidation of certain pyrazolines can afford pyrazoles in a single step.^\[[@cit0013],\ [@cit0017]\]^ Pyrazolines **25-30** were obtained in good to excellent yields (59-82%) over a *15 min* residence time, improving upon previous conditions requiring 14 h.^\[[@cit0013]\]^

A novel n-nitrosopyrazoline byproduct was also observed through a second condensation with ^t^BuONO. Interestingly, pyrazolines **25-30**, or their n-nitroso counterparts **31-33** could be selectively synthesized by simply changing the concentration of ^t^BuONO and AcOH entering the system. For example, pyrazoline **28** was achieved in 75% yield and 97% selectivity through standard conditions (CF~2~HCH~2~NH~2~ (2 equiv), ^t^BuONO (2 equiv), AcOH (0.4 equiv)). Then, increasing the concentration of ^t^BuONO (4 equiv) and AcOH (0.5 equiv) generated the n-nitroso analogue **31** in 98% yield and 94% selectivity.

Subjecting **2** to optimized conditions for n-nitrosopyrazoline formation yielded \<20% in all cases. Single crystal X-ray analysis of **31\*** and **31** revealed that the van der Waals radii of the fluorine atom (147 pm) overlapped with the oxygen atom (152 pm) of the n-nitroso group, suggesting interaction in the solid state. For the CF~2~H moiety however, a strong hydrogen bond is present that could drive the higher yields (46-92%) experimentally observed.

With an assembly line synthesis in mind, modules 1 and 2 were scaled up (2.25 mL and 7.75 mL coils respectively) and combined with Syrris^®^ pumping modules (total flow rate of 750 µL min^-1^) to produce **4** at 2.16 g h^-1^ (87% yield). Next, additional modules to facilitate a range of transformations were explored. We envisaged that N-arylation of **21-24** would yield Celecoxib, Mavacoxib, SC-560 and the human lung cancer suppression candidate. Both DPC-602 and AS-136A could be accessed through N-methylation or arylation of **4** or **6,** and subsequent amidation. Finally, Bixafen, Fluxapyroxad, Sedaxane and Isopyrazam could be achieved through TMS cleavage of **17**, followed by N-methylation, and then amidation ([Fig. 3C](#f0003){ref-type="fig"}). As a proof of concept, individual modules were used to create highly substituted pyrazoles on route to pharmaceuticals and agrochemicals ([Fig. 3](#f0003){ref-type="fig"}).

![**Individual continuous flow modules for the generation of agrochemical and pharmaceutical like targets.** *Module 3*; pyrazole (0.12 M in DCM, 2.0 equiv), Cu(OAc)2 (1.5 equiv in DCM) and pyridine (1.0 equiv in DCM) at 90°C. *Module 4*; pyrazole (0.26 M in DMF, 1.0 equiv), 1,8-Diazabicyclo\[5.4.0\]undec-7-ene (DBU, 4.0 equiv in DMF), iodomethane (MeI, 4.0 equiv in DMF) at 120 °C. *Module 5*; Pyrazole (0.30 M in DMF, 1.0 equiv), 4-fluoroaniline (1.3 equiv in DMF) and lithium bis(trimethylsilyl)amide (3.3 equiv in THF) at 40 °C. *Module 6*; Pyrazole (0.25 M, 1.0 equiv), TBAF (1.75 equiv) and AcOH (1.75 equiv) at 70 °C. For additional details on reactor set-up, see the supporting information](ange-2017-201704529-g003){#f0003}

Module 3 mediates Chan-Lam-Evans C-N arylation ([Fig. 3C](#f0003){ref-type="fig"}). Although notable examples of azole Chan-Lam-Evans couplings exist, these were performed with less demanding azoles.^\[[@cit0018]\]^ Initially, 22% of the desired product was achieved with Ph-B(OH)~2~ after 16 h at 40 °C in a round bottom flask. Removing Et~3~N and translating to continuous-flow with a reactor temperature of 90 °C provided a satisfactory 66% yield. Once again, the use of DCM at 90 °C is well suited for continuous flow; this temperature would be difficult to achieve in a round bottom flask. Module 4 mediates N-methylation ([Fig. 3A and B](#f0003){ref-type="fig"}). Here, the sensitivity of the CF~2~H group became apparent. While **4** can be readily methylated with MeI and tetramethylpiperidine (1 min, microwave, 120 °C, DMF, 99% yield), immediate decomposition of the CF~2~H analogues was observed. Further optimization revealed that DBU and MeI at 120 °C for 10 mins in continuous flow provides suitable conditions to methylate both the di, and tri-fluorinated pyrazoles in good yield. Module 5 performs direct amidation of pyrazole esters; combining solutions of 1M LiHMDS with the pyrazole and amide at 40 °C for 1 min gave the corresponding amides in excellent yields (86-96%, [Fig. 3A-C](#f0003){ref-type="fig"}). Finally, module 6 performs TMS removal ([Fig. 3B](#f0003){ref-type="fig"}). Although KOH at elevated temperatures proved effective for **17** (2 equi. KOH in EtOH, 150 °C, 30 min, microwave), immediate decomposition was observed for **16.** Pleasingly, TBAF (buffered with AcOH) at 70 °C with a 30 min residence time afforded the desired product in 96% yield.

Through a combination of modules 1-6, it is theoretically possible to synthesize a large number of APIs and agrochemicals. To demonstrate this opportunity, measles therapeutic AS-136A was synthesized. Using modules 1 and 2 in a telescoped fashion, and then modules 4 and 5 individually yielded AS-136A (75% yield, 99% purity) for a 26 min total reaction time (Fig. S1). Next, all of the required modules (1, 2, 4 and 5) were telescoped into a single multi-step continuous flow system to produce AS-136A (34% isolated yield, 72% purity) at a rate of 1.73 g h^-1^ ([Fig. 4](#f0005){ref-type="fig"}). Additionally, module 4 not only drives rapid methylation (120 °C, 10-16 min), but controlled gas formation was observed; presumably excess diazoalkane is destroyed releasing N~2~. Furthermore, this telescoped synthesis uses LiHMDS directly from the supplier's bottle removing the need to handle this toxic and flammable substance.

![**Crystal structures for the tri- and di-fluoro n-nitroso pyrazolines.** Highlighted are bond distances from the oxygen of the n-nitroso group to the CF~3~ or CF~2~H moiety.](ange-2017-201704529-g004){#f0004}

![**Continuous flow synthesis of AS-136A.** A continuous flow telescoped synthesis with modules 1,2,4 and 5 to yield measles therapeutic AS-136A in a 34% isolated yield at a rate of 1.73 g h^-1^. Using modules individually yields AS-136A in a 75% yield. See the supporting information for additional details.](ange-2017-201704529-g005){#f0005}

The lower yield observed in the telescoped transformation is due to at least two factors. First, telescoping large sequences means that excess reagents and by-products are carried through to subsequent steps; decreasing yields through unwanted reactivity. In theory, decreasing the amount of excess reagent in each step could aid the telescoped process. However, when experimentally tested, modules 1, 2 and 3 resulted in significantly decreased yields. For example, a 1:1:1.2 ratio of ethyl propiolate: 2,2-difluoroethylamine: ^t^BuONO resulted in only 37% yield compared to 70% when using a 1:2:2.4 ratio. Furthermore, using only two equivalents of MeI in module 3 resulted in 39% yield, compared 100% when using eight (Table S2). Second, using Syrris^®^ pumps decreased the efficiency of module 1 and 2 (75-87% compared to 99%) as uneven fluid delivery is observed at the high back pressure (\~22-24 bar).

In conclusion, a continuous flow platform for the synthesis of valuable, highly functionalized pyrazoles and pyrazolines has been developed. Generating common pyrazole cores for subsequent modification in a range of modules allows a wide breadth of chemical space to be readily and efficiently accessed. Importantly, modules mediate rapid continuous flow chemistry (1--60 min) by operating solvents above their atmospheric boiling points for improved kinetics. This effect removed the need for stoichiometric Ag~2~O and base for terminal aryl alkynes dipolarphiles to participate in \[3+2\] cycloaddition with **2**. To demonstrate the capabilities of this system, AS-136A was synthesized in 75% yield (99% purity) using three sets of individual modules, or through a telescoped continuous flow multi-step process yielding 1.73 g h^-1^ (34% yield, 72% purity) of isolated product. This approach builds upon previous syntheses of this molecule requiring several additional steps and multiple intermediate isolations.^\[[@cit0012],\ [@cit0019]\]^
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**Reaction Modularity Meets Flow:** Assembly lines have been used to synthesize highly functionalized pyrazoles and pyrazolines *on route* to agrochemicals and pharmaceuticals through multi-step, continuous flow synthesis.
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